Literature DB >> 22900975

Redox reactions of myoglobin.

Mark P Richards1.   

Abstract

SIGNIFICANCE: Failure to maintain myoglobin (Mb) in the reduced state causes the formation of metMb, ferryl Mb species, and cross-linked Mb. Dissociation of ferriprotoporphyrin IX from the globin and release of iron atoms can also occur as oxidized Mb accumulates. These modifications may contribute to various oxidative pathologies in muscle and muscle foods. RECENT ADVANCES: The mechanism of ferryl Mb-mediated oxidative damage to nearby structures has been partially elucidated. Dissociation of ferriprotoporphyrin IX from metMb occurs more readily at acidic pH values. The dissociated ferriprotoporphyrin IX (also called hemin) readily decomposes preformed lipid hydroperoxides to reactive oxygen species. Heme oxygenase as well as lipophilic free radicals can degrade the protoporphyrin IX moiety, which results in the formation of free iron. CRITICAL ISSUES: The multiple pathways by which Mb can incur toxicity create difficulties in determining the major cause of oxidative damage in a particular system. Peroxides and low pH activate each of the oxidative Mb forms, ferriprotoporphyrin IX, and released iron. Determining the relative concentration of these species is technically difficult, but essential to a complete understanding of oxidative pathology in muscle tissue. FUTURE DIRECTIONS: Improved methods to assess the different pathways of Mb toxicity are needed. Although significant advances have been made in the understanding of Mb interactions with other biomolecules, further investigation is needed to understand the physical and chemical nature of these interactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22900975      PMCID: PMC3638515          DOI: 10.1089/ars.2012.4887

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  67 in total

1.  Mechanism for the autoxidation of hemoglobin by phenols, nitrite and "oxidant" drugs. Peroxide formation by one electron donation to bound dioxygen.

Authors:  W J Wallace; W S Caughey
Journal:  Biochem Biophys Res Commun       Date:  1975-02-03       Impact factor: 3.575

2.  Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation.

Authors:  Brandon J Reeder; Michael T Wilson
Journal:  Chem Res Toxicol       Date:  2005-06       Impact factor: 3.739

3.  Covalent crosslinking of the heme prosthetic group to myoglobin by H2O2: toxicological implications.

Authors:  Y Osawa; M S Williams
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

4.  The effects of pH on the mechanism of hydrogen peroxide and lipid hydroperoxide consumption by myoglobin: a role for the protonated ferryl species.

Authors:  B J Reeder; M T Wilson
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

5.  Peroxidation of linoleate at physiological pH: hemichrome formation by substrate binding protects against metmyoglobin activation by hydrogen peroxide.

Authors:  C P Baron; L H Skibsted; H J Andersen
Journal:  Free Radic Biol Med       Date:  2000-02-15       Impact factor: 7.376

6.  Reduction of hypervalent states of myoglobin and hemoglobin to their ferrous forms by thymoquinone: the role of GSH, NADH and NADPH.

Authors:  K H Khalife; G Lupidi
Journal:  Biochim Biophys Acta       Date:  2007-12-23

7.  The mechanism of autooxidation of myoglobin.

Authors:  R E Brantley; S J Smerdon; A J Wilkinson; E W Singleton; J S Olson
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

8.  Structural factors governing hemin dissociation from metmyoglobin.

Authors:  M S Hargrove; A J Wilkinson; J S Olson
Journal:  Biochemistry       Date:  1996-09-03       Impact factor: 3.162

9.  Mechanism of the biphasic effect of ethylenediaminetetraacetate on lipid peroxidation in iron-supported and reconstituted enzymatic system.

Authors:  Y Tampo; S Onodera; M Yonaha
Journal:  Free Radic Biol Med       Date:  1994-07       Impact factor: 7.376

Review 10.  The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology.

Authors:  Brandon J Reeder; Dimitri A Svistunenko; Christopher E Cooper; Michael T Wilson
Journal:  Antioxid Redox Signal       Date:  2004-12       Impact factor: 8.401

View more
  12 in total

1.  Quantification of Active Apohemoglobin Heme-Binding Sites via Dicyanohemin Incorporation.

Authors:  Ivan S Pires; Donald A Belcher; Andre F Palmer
Journal:  Biochemistry       Date:  2017-09-20       Impact factor: 3.162

2.  A peroxidase mimetic protects skeletal muscle cells from peroxide challenge and stimulates insulin signaling.

Authors:  Amanda M Eccardt; Ross J Pelzel; Lyn Mattathil; Yerin A Moon; Mark H Mannino; Blythe E Janowiak; Jonathan S Fisher
Journal:  Am J Physiol Cell Physiol       Date:  2020-04-29       Impact factor: 4.249

3.  Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation.

Authors:  Andrea Braganza; Kelly Quesnelle; Janelle Bickta; Christopher Reyes; Yinna Wang; Morgan Jessup; Claudette St Croix; Julie Arlotti; Shivendra V Singh; Sruti Shiva
Journal:  J Biol Chem       Date:  2019-03-14       Impact factor: 5.157

Review 4.  Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.

Authors:  Zhengnan Yuan; Ladie Kimberly De La Cruz; Xiaoxiao Yang; Binghe Wang
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

5.  Roles of multiple-proton transfer pathways and proton-coupled electron transfer in the reactivity of the bis-FeIV state of MauG.

Authors:  Zhongxin Ma; Heather R Williamson; Victor L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

6.  A novel thermophilic hemoprotein scaffold for rational design of biocatalysts.

Authors:  Joana Efua Aggrey-Fynn; Nur Basak Surmeli
Journal:  J Biol Inorg Chem       Date:  2018-09-12       Impact factor: 3.358

7.  Genetically encoded FRET probes for direct mapping and quantification of intracellular oxygenation level via fluorescence lifetime imaging.

Authors:  Alessio Andreoni; Rozhin Penjweini; Branden Roarke; Marie-Paule Strub; Dan L Sackett; Jay R Knutson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-02-22

8.  Pseudoperoxidase activity, conformational stability, and aggregation propensity of the His98Tyr myoglobin variant: implications for the onset of myoglobinopathy.

Authors:  Stefan Hofbauer; Marcello Pignataro; Marco Borsari; Carlo Augusto Bortolotti; Giulia Di Rocco; Gianina Ravenscroft; Paul G Furtmüller; Christian Obinger; Marco Sola; Gianantonio Battistuzzi
Journal:  FEBS J       Date:  2021-11-03       Impact factor: 5.622

9.  Selective Radical Trifluoromethylation of Native Residues in Proteins.

Authors:  Mateusz Imiołek; Gogulan Karunanithy; Wai-Lung Ng; Andrew J Baldwin; Véronique Gouverneur; Benjamin G Davis
Journal:  J Am Chem Soc       Date:  2018-01-22       Impact factor: 15.419

10.  Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic sarcoplasmic inclusions.

Authors:  Montse Olivé; Martin Engvall; Gianina Ravenscroft; Macarena Cabrera-Serrano; Hong Jiao; Carlo Augusto Bortolotti; Marcello Pignataro; Matteo Lambrughi; Haibo Jiang; Alistair R R Forrest; Núria Benseny-Cases; Stefan Hofbauer; Christian Obinger; Gianantonio Battistuzzi; Marzia Bellei; Marco Borsari; Giulia Di Rocco; Helena M Viola; Livia C Hool; Josep Cladera; Kristina Lagerstedt-Robinson; Fengqing Xiang; Anna Wredenberg; Francesc Miralles; Juan José Baiges; Edoardo Malfatti; Norma B Romero; Nathalie Streichenberger; Christophe Vial; Kristl G Claeys; Chiara S M Straathof; An Goris; Christoph Freyer; Martin Lammens; Guillaume Bassez; Juha Kere; Paula Clemente; Thomas Sejersen; Bjarne Udd; Noemí Vidal; Isidre Ferrer; Lars Edström; Anna Wedell; Nigel G Laing
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.